In an adult with uncomplicated cystitis and normal renal function who is not pregnant, what is the recommended nitrofurantoin dosing, contraindications, and alternative therapies?

Nitrofurantoin for Uncomplicated Cystitis

Nitrofurantoin 100 mg orally twice daily for 5 days is the preferred first-line therapy for uncomplicated cystitis in non-pregnant adults with normal renal function, achieving approximately 93% clinical cure and 88% microbiological eradication with worldwide resistance rates below 1%. 1

Recommended Dosing

• Standard regimen: Nitrofurantoin monohydrate/macrocrystals 100 mg orally twice daily for 5 days for uncomplicated cystitis in adults. 1
• This 5-day course is equivalent in effectiveness to a 3-day trimethoprim-sulfamethoxazole regimen and should not be shortened. 1, 2
• For treatment failures requiring retreatment, extend the duration to 7 days with a different antibiotic class. 1

Absolute Contraindications

• Estimated glomerular filtration rate (eGFR) < 30 mL/min/1.73 m² – therapeutic urinary concentrations cannot be achieved at this level of renal impairment. 1, 3
• Pyelonephritis or upper urinary tract infections – nitrofurantoin does not achieve adequate tissue concentrations for upper-tract disease. 1
• Infants under 4 months of age – risk of hemolytic anemia. 1
• Last trimester of pregnancy (after 36 weeks gestation) – theoretical risk of neonatal hemolytic anemia. 3

Renal Function Considerations

• eGFR ≥ 60 mL/min/1.73 m²: Use standard dosing without adjustment; nitrofurantoin shows superior efficacy to fosfomycin or trimethoprim in this population. 4
• eGFR 30–60 mL/min/1.73 m²: Nitrofurantoin can be used with caution, though clinical failure rates increase by approximately 5% per 10 mL/min decrease in eGFR. 5, 4 In this range, fosfomycin may be preferred as it shows better efficacy than nitrofurantoin when eGFR < 60 mL/min. 4
• eGFR < 30 mL/min/1.73 m²: Avoid nitrofurantoin entirely; switch to fosfomycin 3 g single dose or trimethoprim-sulfamethoxazole if local resistance is < 20%. 1, 3

Alternative First-Line Therapies

When Nitrofurantoin Cannot Be Used

• Fosfomycin trometamol 3 g as a single oral dose – achieves approximately 91% clinical cure, maintains therapeutic urinary concentrations for 24–48 hours, and has only 2.6% resistance in initial E. coli infections. 1, 3

  • Do not use for pyelonephritis – insufficient tissue penetration. 3
  • Preferred over nitrofurantoin when eGFR is 30–60 mL/min. 4

• Trimethoprim-sulfamethoxazole (TMP-SMX) 160/800 mg orally twice daily for 3 days – achieves 93% clinical cure and 94% microbiological eradication. 1

  • Use only when local E. coli resistance is < 20% and the patient has not received TMP-SMX in the preceding 3 months. 1, 3
  • Many regions now exceed the 20% resistance threshold, making verification of local antibiogram data mandatory. 1

Reserve (Second-Line) Agents

Use Only After Culture-Proven Resistance or First-Line Failure

• Fluoroquinolones (ciprofloxacin 250–500 mg twice daily or levofloxacin 250–750 mg once daily for 3 days) – should be reserved exclusively for culture-proven resistant organisms. 1, 3

  • The FDA issued warnings in 2016 about serious adverse effects (tendon rupture, peripheral neuropathy, CNS toxicity) that outweigh benefits in uncomplicated cystitis. 1
  • Global fluoroquinolone resistance is rising, with some regions reporting > 10% resistance. 1

• Beta-lactams (amoxicillin-clavulanate, cefdinir, cefpodoxime for 3–7 days) – achieve only 89% clinical cure and 82% microbiological eradication, significantly inferior to first-line agents. 1, 3

  • Amoxicillin or ampicillin alone should never be used – worldwide E. coli resistance exceeds 55–67%. 1, 3

Clinical Advantages of Nitrofurantoin

• Minimal disruption of intestinal flora compared to fluoroquinolones and cephalosporins, thereby reducing the risk of Clostridioides difficile infection. 1, 6
• Retains activity against multidrug-resistant organisms, including ESBL-producing E. coli, with resistance rates remaining below 1% worldwide. 1, 6
• Extremely low risk of serious adverse effects with short-term use – pulmonary toxicity occurs in 0.001% and hepatic toxicity in 0.0003% of patients. 1

When to Obtain Urine Culture

Routine urine culture is not required for otherwise healthy women with typical cystitis symptoms. 1, 3

Mandatory Culture Indications

• Persistent symptoms after completing the prescribed regimen. 1
• Recurrence of symptoms within 2–4 weeks. 1
• Fever > 38°C, flank pain, or costovertebral angle tenderness suggesting pyelonephritis. 1
• Atypical presentation or presence of vaginal discharge. 1
• History of recurrent infections or prior isolation of resistant organisms. 1
• Pregnancy with urinary symptoms. 3

Management of Treatment Failure

• Obtain urine culture and susceptibility testing immediately when symptoms persist or recur within 2 weeks. 1
• Switch to a different antibiotic class for a full 7-day course (not the original 5-day regimen). 1
• Assume the original pathogen is resistant to the previously used agent. 1
• If fever persists beyond 72 hours, perform renal ultrasound or CT imaging to exclude obstruction or abscess. 1

Critical Pitfalls to Avoid

• Do not treat asymptomatic bacteriuria in non-pregnant, non-catheterized patients – this promotes resistance without clinical benefit. 1, 3
• Do not prescribe nitrofurantoin for suspected pyelonephritis – switch to a fluoroquinolone or parenteral cephalosporin. 1
• Do not use nitrofurantoin when eGFR < 30 mL/min/1.73 m² – therapeutic urinary concentrations cannot be achieved. 1, 3
• Do not repeat the same antibiotic after treatment failure – assume resistance and switch to a different mechanism of action. 1
• Do not prescribe TMP-SMX without confirming local E. coli resistance is < 20% – failure rates increase sharply above this threshold. 1

Special Populations

Pregnancy

• Nitrofurantoin is safe throughout pregnancy except after 36 weeks gestation. 3
• For pregnant women, consider fosfomycin 3 g single dose or a short course (3–7 days) of nitrofurantoin or beta-lactam antibiotics. 3

Elderly Patients

• Standard dosing applies for elderly patients with normal renal function. 1
• In elderly patients with CrCl < 30 mL/min, avoid both nitrofurantoin and TMP-SMX according to American Geriatrics Society consensus. 1

Recurrent UTIs

• Nitrofurantoin may be used as prophylaxis when non-antimicrobial interventions have failed. 1
• Obtain urine culture with each symptomatic episode prior to initiating treatment. 1